Clinical Study
Influencing factors of death in intensive care unit patients with acute respiratory distress syndrome combined with acute kidney injury after continuous renal replacement therapy
Huang Yajun, Gu Yue, Zhang Wenwen, Gao Mei, Sheng Yijia, Ren Yingying, Yan Lei, Shao Fengmin
Published 2021-09-15
Cite as Chin J Nephrol, 2021, 37(9): 723-729. DOI: 10.3760/cma.j.cn441217-20201019-00107
Abstract
ObjectiveTo analyze the influencing factors of death in patients with acute respiratory distress syndrome (ARDS) combined with acute kidney injury (AKI) in intensive care unit (ICU) after continuous renal replacement therapy (CRRT).
MethodsThe demographic and clinical data of ICU patients with ARDS combined with AKI after CRRT at Henan Provincial People's Hospital from January 1, 2018 to December 31, 2018 were collected. According to the final treatment results of this hospitalization, the patients were divided into death group and survival group. Survival was defined as the improved patient's condition and hospital discharge. Death was defined as the patient's death during the ICU hospitalization or confirmed death after abandoning treatment and automatically being discharged from the hospital in the follow-up. The basic clinical characteristics and CRRT status between the two groups were compared. Multivariate logistic regression method was used to analyze the influencing factors of death in patients.
ResultsA total of 132 patients were enrolled, of which 90 patients (68.2%) died, with 84 males (63.6%) and median age of 59(45, 73) years. Compared with the survival group, the death group had higher age, proportion of malignant tumors, sequential organ failure assessment (SOFA) score, number of organ dysfunction and proportion of positive balance of fluid accumulation at 72 hours, longer time from entering ICU to CRRT, and lower mean arterial pressure (minimum value) and oxygenation index (all P<0.05). Multivariate logistic regression analysis results showed that the age≥60 years old (OR=4.382, 95%CI 1.543-12.440, P=0.006), large number of organ dysfunction (OR=1.863, 95%CI 1.109-3.130, P=0.019), high SOFA score (OR=1.231, 95%CI 1.067-1.420, P=0.004) and long time from ICU admission to CRRT (OR=1.224, 95%CI 1.033~1.451, P=0.020) were independent influencing factors of death in patients with ARDS combined with AKI after CRRT, and high oxygenation index (OR=0.992, 95%CI 0.986-0.998, P=0.010) was an independent protective factor for patients' prognosis.
ConclusionsThe mortality of patients with ARDS combined with AKI after CRRT is still high. The age≥60 years old, large number of organ dysfunction, high SOFA score and long time from ICU admission to CRRT are independent influencing factors for death, and high oxygenation index is an independent protective factor for prognosis in patients with ARDS combined with AKI after CRRT.
Key words:
Respiratory distress syndrome, adult; Acute kidney injury; Renal replacement therapy; Mortality; Risk factors
Contributor Information
Huang Yajun
Department of Nephrology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou 450003, China
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Gu Yue
Department of Nephrology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou 450003, China
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Zhang Wenwen
Department of Nephrology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou 450003, China
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Gao Mei
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Sheng Yijia
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Ren Yingying
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Yan Lei
Department of Nephrology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou 450003, China
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China
Shao Fengmin
Department of Nephrology, Henan Provincial People's Hospital (People's Hospital of Zhengzhou University), Zhengzhou 450003, China
Henan Key Laboratory of Kidney Disease and Immunology, Zhengzhou 450003, China